Fujifilm Synapse Mobility Enterprise Web Viewer is Granted Authority to Operate on DoD Networks
STAMFORD, Conn.--(BUSINESS WIRE)--FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, today announced that its Synapse Mobility Enterprise Web Viewer has been granted Authority to Operate (ATO) on networks in the U.S. Department of Defense (DoD). The DoD awards an ATO according to a risk-based framework that analyzes a technology’s security controls within their IT environment.
“With data breaches as a continued concern in the healthcare industry, there is no greater affirmation of Fujifilm’s dedication to risk mitigation and protecting sensitive information than a ‘green light’ from the DoD”
“We are proud and gratified that Fujifilm’s Synapse Mobility Enterprise Viewer is now authorized for use at the U.S. Department of Defense,” said Johann Fernando, Ph.D, Chief Operating Officer, FUJIFILM Medical Systems U.S.A., Inc. “This ATO is a major accomplishment for Fujifilm and testifies to our ongoing commitment to bringing to market innovative technology that adheres to the most stringent security standards.”
After completing a thorough security assessment, the DoD determined that Synapse Mobility can be configured to meet its controls for Risk Management Framework. Specifically, Synapse Mobility can be configured to meet the DoD 8500 series and DISA STIG requirements.
DoD controls are customizable and implemented as part of an organization-wide process that manages information security and privacy risk. The controls address a diverse set of security and privacy requirements across the federal government and critical infrastructure, derived from legislation, Executive Orders, policies, directives, regulations, standards, and/or mission/business needs.
Fujifilm’s Synapse Mobility Enterprise Web Viewer utilizes the latest server-side rendering technology, allowing providers to securely and quickly view all patient imaging data to authorized users without downloading any patient data locally. The web viewer can be accessed directly via web browsers or launched directly from the secure EHR. It includes support for dual factor authentication via the Common Access Card (CAC), a zero-footprint DICOM and non-DICOM image and report viewer for the holistic patient record, a federated data search across disparate archives to present a single patient timeline, and a Share feature to launch other 3rd party integrations.
“With data breaches as a continued concern in the healthcare industry, there is no greater affirmation of Fujifilm’s dedication to risk mitigation and protecting sensitive information than a ‘green light’ from the DoD,” said Bill Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems U.S.A., Inc. “We view it as a vote of confidence in our company and trust in Fujifilm technology.”
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.